CDSCO approves ‘Palivizumab’, a long-awaited preventive therapy for Respiratory Syncytial Virus September 30, 2023 AstraZeneca Pharma India on Saturday announced the marketing approval from Central Drugs Standard Control Organisation (CDSCO) to import and market ‘Palivizumab’ injection 100 mg/ml (r-DNA origin) (50mg/0.5mL &... Trending Safdarjung Hospital starts Bone Marrow Transplant facility after AIIMS President Murmu presides over AGM of Indian Red Cross Society What triggers criminals for sudden cold-blooded murders, explains top Psychiatrist Latest Cancer Awareness, Prevention and Screening camp held at Tis Hazari Court Complex Over 90% Glaucoma cases undiagnosed in India, experts at AbbVie Conclave Common among women of reproductive age-group, AIIMS warns of rising prevalence of autoimmune disease FORDA objects NBEMS decision of lowering NEET-PG scores, demands withdrawal of decisions
